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Background. The molecular basis of renal aging is not com-
pletely understood.
Methods. We used global gene expression monitoring by
cDNA microarrays to identify age associated genes in human
kidney samples. Our samples included young (8 weeks–8 years,
N = 4), adult (31–46 years, N = 7), and old kidneys (71–88 years,
N = 9).
Results. Old kidneys had more glomerulosclerosis, tubular at-
rophy, interstitial fibrosis, and fibrous intimal thickening in small
arteries. We identified ∼500 genes that were differentially ex-
pressed among the three age groups. Old kidneys appeared to
have increased extracellular matrix turnover and a nonspecific
inflammatory response, combined with a reduction in processes
dependent on energy metabolism and mitochondrial function.
Quantitative supervised bioinformatics analyses of adult and
old kidney expression data correlated the expression of 255
gene profiles with renal pathology scores. Microarray class pre-
diction analysis (PAM) identified 50 unique genes that segre-
gated old kidneys into two distinct clusters: those more similar
within age class (OO, N = 5) versus old kidneys more similar
to adult kidneys (OA, N = 4). The expression of six function-
ally significant genes was further validated by quantitative re-
verse transcription-polymerase chain reaction (RT-PCR) (FN1,
MMP7, TNC, SERPIN3A, BPHL, CSPG2) in the experiment
group and, subsequently, confirmed independently in 17 addi-
tional old and adult age-stratified test kidney samples. The p53
inducible gene, CSPG2, performed best in separating OO kid-
neys from adults and OA samples in this analysis.
Conclusion. The method described in this study using inde-
pendent validation samples can be envisioned to test utility of
the identified genes in assessing age-related changes that con-
tribute to decline in renal function.
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Age-associated changes in kidney are important not
only because normal aging alters renal function but also
because of the high frequency of end-stage renal disease
(ESRD) in the elderly [United States Renal Data Sys-
tem Report (USRDS) 2003]. The incidence of acute re-
nal failure is higher in older subjects (USRDS Report
2003), and the clinical outcome of renal failure is signifi-
cantly worse with regard to mortality, requirement of dial-
ysis, and complete recovery [1]. Old kidneys also perform
poorly when transplanted, and donor age remains a ma-
jor determinant for donor selection and of graft survival
[2]. Interactions between aging and diseases may also
contribute to these problems. Understanding the mech-
anisms underlying age-related decline in organ function
and the role of stress in accelerating these changes may
be relevant to the mechanisms of progression of chronic
renal insufficiency. Kidney aging is also of interest as a
general model for organ aging because renal function can
be assessed with relative ease in clinical practice, and has
been quantified in longitudinal studies [3].
The phenotype of human renal aging is a phenotype
of loss: loss of mass, particularly in cortex [4, 5], and loss
of function, with increased renal vascular resistance, re-
duced renal plasma flow, and increased filtration fraction
[5, 6]. Estimates of glomerular filtration rate (GFR) us-
ing multiple equations such as Cockcroft-Gault [7] and
Modified Diet in Renal Disease (MDRD) [8] equation
show declines in GFR with age. Studies in selected pop-
ulations ([9] and Baltimore Longitudinal Study of Aging
[4]), excluding all renal diseases, hypertension, and heart
failure, demonstrated mean loss of glomerular filtration
rate of 0.75 mL/min per year [4]. They also found that
one [4] to two [9] thirds of the elderly manifested little
if any decline in glomerular filtration rates. The principal
histologic features of renal aging are glomerulosclerosis,
tubular atrophy, interstitial fibrosis, and fibrous thicken-
ing of the intimal of arteries [10]. Although it is unclear
whether these changes are primary or secondary events,
2667
2668 Melk and Mansﬁeld et al: Transcriptional analysis using cDNA microarray proﬁling
they do reflect degeneration and loss of nephrons. In the
presence of age-related diseases, such as hypertension
and heart failure, these changes can be accelerated [9].
The molecular basis of renal aging is not known. The
decrease in renal hemodynamics could be explained by
either potentially reversible functional changes due to an
imbalance between factors controlling vasodilatation and
vasoconstriction, or they could be the result of the irre-
versible morphologic changes. We have shown previously
that kidney aging is associated with changes that are char-
acteristic of somatic cell senescence and irreversible cell
cycle arrest in vitro [11–13]. We found telomere shorten-
ing and increased expression of the cell cycle regulator
p16INK4a in kidneys from older individuals with normal
renal function and histopathologic features within the
range expected for age, suggesting that renal function
under normal conditions is not affected by these features
[12, 13]. This is supported by the clinical observation that
ESRD, although greatly increased in the elderly, is still
uncommon, and that the majority of the elderly with-
out other age-related diseases have normal renal func-
tion (USRDS Report 2003). We have interpreted these
findings to indicate that telomere shortening and p16INK4a
expression results in a limited ability of the aged nephron
to replicate and thereby lead to the diminished capacity
of older kidneys to cope and withstand normal and ab-
normal stresses [14, 15].
The objective of the presented study was to extend our
knowledge on the molecular basis of renal aging. We were
looking for molecular markers that add to the existing
measurements of renal age, such as histologic findings
and chronologic age, and might predict how a kidney will
function under certain stresses (e.g., transplantation or
renal disease).
METHODS
Kidney samples
We studied a total of 20 human kidney cortex samples
that reflected three different age groups: young (mean
age 3–1 years; N = 4), adult (mean age 38.1 years; N =
7), and old (mean age 78.5 years; N = 9; Table 1). All
individuals were Caucasian, except for two children that
were of Native Canadian descent. None of the patients
had diabetes mellitus or uncontrolled arterial hyperten-
sion. Samples were derived from total nephrectomies
(N = 18) and autopsies (N = 2). In the case of tumor
nephrectomies, normal renal tissue remote from the tu-
mor was chosen for analysis. The histology of all 20 sam-
ples was within normal limits of changes expected for age
[16–20]. All tissue samples were snap-frozen in liquid ni-
trogen and stored at −70◦C for transcriptional studies,
and paraffin embedded for histopathologic assessment.
The study was approved by the Health Research Ethics
Table 1. Demographic data and histological grading
Young Adult Old
(N = 4) (N = 7) (N = 9)
Age years
Mean ± SD 3.1 ± 3.5 38.1 ± 5.1 75.8 ± 5.3
Range 8 weeks–8 years 31–46 years 71–88 years
Gender f/m 1/3 4/3 5/4
Creatinine lmol/L 28.0 ± 11.4 91.9 ± 21.9 91.9 ± 16.9
Systolic blood 84.8 ± 10.1 124.6 ± 20.4 145.9 ± 23.4
pressure mm Hg
Diastolic blood 41.0 ± 5.9 76.6 ± 9.1 78.4 ± 15.0
pressure mm Hg
Proteinuria None None None
History of hypertension 1 (25%) 1 (14%) 11 (44%)
Glomerulosclerosis %
Mean ± SD 0.33 ± 0.58 2.57 ± 1.72 8.22 ± 3.07
Range 0–1 0–5 0–11
Interstitial fibrosis %
Mean ± SD 0 0.57 ± 1.13 3.56 ± 1.94
Range 0 0–3 2–8
Tubular atrophy %
Mean ± SD 0 1.21 ± 2.31 3.78 ± 1.86
Range 0 0–6 1–6
Fibrous intimal
thickening %
Mean ± SD 0 5.29 ± 5.19 17.63 ± 14.92
Range 0 0–14 0–51
Arteriolar hyalinosis
score
Mean ± SD 0 0.17 ± 0.41 0.88 ± 0.64
Range 0 0–1 0–2
Detailed information on histopathologic chronicity scores for each individual
study subject can be found in Supplemental Table 1.
Board of the University of Alberta, Edmonton, and the
Institutional Review Board at Stanford University.
Pathology
Histopathologic assessment of age-related renal
changes was performed for all four compartments of the
kidney: glomeruli, tubules, interstitium, and vessels, in a
blinded manner by a renal pathologist (D.C.R.) These
scores have been listed as mean pathology scores for
age (Table 1), as well as individual pathology scores
in the study subjects analyzed (Supplemental Table 1
at http://microarray-pubs.stanford.edu/renalaging/). In-
terstitial fibrosis and tubular atrophy were expressed as
percentage of parenchymal involvement based on exam-
ination of at least 10 high power fields (magnification
400×). In addition, interstitial fibrosis was assessed using
Sirius Red staining (see below). Glomerulosclerosis was
expressed as percentage of globally sclerosed glomeruli
based on all glomeruli present in the section. We counted
a mean of 143 glomeruli per sample with a range from
18 to 345 glomeruli present in the cortex. Fibrous inti-
mal thickening was assessed as percentage of occlusion
of arterial lumen across all vessels present in the section.
We assessed between 3 to 18 cross-sections per speci-
men. Arteriolar hyaline thickening was assessed based
on the Banff classification [16], with 0 = no PAS positive
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hyaline thickening; 1 = mild-to-moderate PAS-positive
hyaline thickening in at least one arteriole; 2 = moderate-
to-severe PAS-positive hyaline thickening in more than
one arteriole; 3 = severe PAS-positive hyaline thickening
in many arterioles.
Sirius red staining
Unstained paraffin-embedded sections were baked at
60◦C for one hour. Slides were soaked in xylene for
24 hours followed by acetone for 24 hours to reduce paraf-
fin contamination. Then, slides were taken through xy-
lene and graded ethanols into distilled water and stained
overnight in saturated picric acid with 0.1% Sirius Red
F3BA (Aldrich Chemicals, Oakville, Ontario, Canada).
Slides were washed in hydrochloric acid (0.01N) and
rapidly dehydrated and mounted.
Image analysis was performed by a technician blinded
to the source of the sample. The slides were exam-
ined with a Nikon E600 microscope (Nikon, Mississauga,
Ontario, Canada), and a Hitachi analogue 3 CCD cam-
era (Hitachi, Mississauga, Ontario, Canada) was used to
capture gray scale 256-bit images that were archived as
TIFF files. A background image was initially obtained
and background correction was performed in real time
while the images were being acquired using the 40× ob-
jective. Images of the kidney cortex were obtained in a
serpentine fashion starting at one end of the tissue and
working toward the other. Large glomeruli, vessels larger
than the size of adjacent tubules, and the medulla were
not included in the image acquisition. Image analysis was
performed using an automated macro (available from
P.G.) specially written for the software package NIH Im-
age (National Institutes of Health, Bethesda, MD, USA).
Automated analysis of the images was performed with
operator supervision. Data are expressed as cortical frac-
tional interstitial fibrosis volume (VIntFib); a value of 1
would reflect 100% fibrosis.
RNA extraction and microarray hybridization
Total RNA was extracted from tissue samples as de-
scribed previously [11, 17]. RNA quality was checked by
Northern blotting. Isolation of mRNA from total RNA
was done using Invitrogen Kit (Invitrogen Canada, Inc.,
Burlington, Ontario, Canada). A “common reference”
RNA pool [18] was used as an internal standard for mi-
croarray experiments. The microarray platform was the
human 42,000 cDNA array, containing 29,043 unique hu-
man genes and 13,103 genes with known function [19].
Standard protocols for amplification, labelling, and pro-
cessing of cDNA microarrays were used as previously
described [20] and can also be found in further detail at
http://microarray-pubs.stanford.edu/renalaging/.
Microarray analysis
All microarray data were stored in the Stanford Mi-
croarray database [21, 22] and gene lists filtered at re-
trieval. A subset of 2778 cDNA clones were found to be
differentially expressed using a cutoff of to log2 >1 in at
least one array and 80% representative data. The expres-
sion data were subjected to statistical analysis to iden-
tify differentially expressed genes, specific for age class,
using the statistical analysis of microarray (SAM) [23],
predictive analysis of microarray (PAM) [24], and singu-
lar value decomposition (SVD; [25]) programs. Cluster
(version 3.0) generated hierarchic clusters by measuring
similarity of expression of the genes and similarity across
arrays that were displayed with the TreeView program
[26].
Real-time reverse transcription (RT) polymerase chain
reaction (PCR)
Transcription into cDNA was done using MMLV re-
verse transcriptase and random primers (Life Technolo-
gies, Burlington, Ontario, Canada) [27, 28]. cDNA was
amplified in an ABI PRISM 7700 Sequence Detector
(Applied Biosystems, Foster City, CA, USA). Assay on
Demand reagents (Applied Biosystems) were purchased.
Quantification of gene expression was performed using
the delta Ct method (Applied Biosystems). Each gene of
interest was normalized to a housekeeping gene (hypox-
anthine guanine phosphoribosyl transferase, HPRT). All
samples were analyzed in duplicate.
Immunohistochemistry
Immunoperoxidase staining for CD79 was performed
using 2 lm sections of paraffin-embedded tissue using
standard protocols based on antigen retrieval. Kidney tis-
sue sections were cooked in citrate buffer, immersed in
3% H2O2 in methanol, blocked with 20% normal goat
serum, incubated for two hours at room temperature
with the primary antibodies (CD79a; Dako, Mississauga,
Ontario, Canada) and rinsed with phosphate-buffered
saline (PBS). Following 30 minutes of incubation with
the Envision monoclonal system (Dako), sections were
washed again in PBS. Visualization was performed using
the DAB substrate kit (Dako). The slides were counter-
stained with hematoxylin and mounted.
Statistical data analysis
The SAS statistical analysis package and Multitest pro-
cedure (SAS Institute, Inc., Cary, NC, USA) were used
to determine statistical significance of PCR and immuno-
histochemistry data. Individual PCR measurements were
averaged and groups compared using Student t test. An
F-statistic cut-off of P < 0.05 was used as threshold for de-
termining significance. Statistical utilities in Excel (t test,
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Fig. 1. Pie diagram for genes associated with renal age. Statistical Analysis of Microarray (SAM) multiclass response analysis identified 505
transcripts in kidney samples from three age groups (young, N = 4; adult, N = 7; old, N = 9) to be significantly differentially expressed (q<5%).
The cellular function of these genes is reflected in this pie diagram. See supplemental Table 2 (http://microarray-pubs.stanford.edu/renalaging/) for
full description of the genes, significance scores, and average fold differences among the three sample groups.
correlation, linear regression, coefficient of variation
and variance; Microsoft Corporation, Redmond, WA,
USA) were also used to rank significance of genes. The
SAM quantitative response was used to correlate gene
expression measurements with clinical parameters re-
ported in Supplemental Table 1 (http://microarray-pubs.
stanford.edu/renalaging/) to generate the pathology-
associated gene lists. The two-class (unpaired) and multi-
class response utilities in SAM (version 1.12) were used to
assess gene expression fold-differences and significance
of genes correlating with age groups. Functional enrich-
ment of genes based on gene ontology annotations were
assessed using the EASE expression analysis explorer
software tool ([29]; http://apps1.niaid.nih.gov/david/). All
supplemental tables and figures can be accessed at
http://microarray-pubs.stanford.edu/renalaging/.
RESULTS
Histopathology analyses
Old kidneys had significantly greater chronicity scores
for all parameters studied when compared to adult kid-
neys: the mean values for sclerosed glomeruli were 8%
(P < 0.05 vs. adult), for interstitial fibrosis and tubular
atrophy 4% (P < 0.05 vs. adult), and for fibrous inti-
mal thickening 18% (P < 0.05 vs. adult). These values
were similar to published histopathologic changes in
the kidney with age [30–34], though glomerulosclero-
sis was lower in our old kidney cohort (Table 1) be-
cause up to 20% of glomerular sclerosis is considered
within the normal range for age [30–32]. As 18 sam-
ples were derived from tumor nephrectomy’s “normal”
renal tissue remote from tumor, a potential problem
of excess global sclerosis existed. Although this caveat
cannot be excluded, given the low glomeruloclerosis
scores, it does not seem likely. Consistent with age,
the 8-week-old infant showed some immature juvenile
glomeruli with prominent cuboidal epithelial cells. In-
terstitial fibrosis and tubular atrophy never exceeded
10% of the total area analyzed in any of the sam-
ples studied. Mean and standard deviation of scores
for each pathologic parameter are shown in Table 1.
Individual chronicity scores for each sample are also
shown in Supplemental Table 1 (http://microarray-pubs.
stanford.edu/renalaging/).
Microarray analyses
Hierarchic unsupervised clustering of the expression
data from the 20 human renal cortex samples did not
cluster samples by age groups (Supplemental Figure 1A
and B; http://microarray-pubs.stanford.edu/renalaging/),
suggesting that age specific transcriptional changes are
dominated by expression differences relating to patient
heterogeneity. Age-related transcriptional changes were
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thus queried by supervised multiclass analysis across the
three age groups using SAM. This identified a renal-aging
gene set of 505 genes with high significance scores (q score
<5%). Functionally characterizing these genes by ontol-
ogy groups suggests that the age-specific changes largely
relate to changes in cell integrity, cellular proliferation,
cell transport, and energy metabolism (Fig. 1; for details
of all genes see Supplemental Table 2; http://microarray-
pubs.stanford.edu/renalaging/). Separation of genes spe-
cific to kidney age-groups is discussed below and shown
in Figure 2.
Renal transcriptional changes with age
In this relative comparison of transcriptional changes
relating to age, many cellular and metabolic processes
showed declining expression with age, with 67% of
the 505 gene-set down-regulated in old kidneys. Sig-
nificant genes within this old kidney dataset suggested
a reduction in energy metabolism via the respiratory
chain [electron transfer flavoprotein-b (ETFB) and
NADH dehydrogenase 1a (NDUFA10)], altered glucose
and lipid metabolism (for example, aldolase-B and -C
and apolipoprotein-D, -E, and -M), as well as re-
duced protein, amino acid, and nucleotide turnover.
Examples of the latter genes include prenyl-cysteine
oxidase 1 (PCL1), kynureninase (KYNU), formimino-
transferase cyclodeaminase (FTCD), phenylalanine hy-
droxylase (PAH), aromatic L-amino acid decarboxylase
(DDC), and cytosine-5-methyltransferase (DNMT2).
In keeping with increased fibrosis, glomeruloclerosis,
and tubular atrophy in old kidneys, there was altered
expression of cytoskeletal genes [including kelch-like 3
(KLHL3), dynein light chain (DNALI1), claudin-8
(CLDN8), kinesin family member 13B (KIF13B), devel-
opmentally down-regulated 5 (NEDD5), microtubule-
associated protein tau (MAPT), and phosphatidylino-
sitol-4-phosphate 5-kinase (PIP5K1B), which is thought
to be involved in the organization of the actin cytoskele-
ton]. In addition, there is evidence of increased extracel-
lular matrix synthesis and turnover [genes include matrix
metalloproteinase 7 (MMP7), fibulin-1 and -2, fibronectin
1 (FN1), tenascin (TNC), chondroitin sulfate proteogly-
can 2 (CSPG2), and alpha-1-antichymotrypsin, or ser-
ine proteinase inhibitor A3 (SERPINA3)], as well as
reduced collagen catabolism via the PEPD peptidase-D
gene. The insulin/insulin-like growth factor pathway has
previously been implicated in aging; we found decreased
expression of the tyrosine 3-monooxygenase/tryptophan
5-monooxygenase activation protein YWHAZ that in-
teracts with insulin receptor substrate proteins IRS1 and
IRS2, which are known to be involved in insulin sig-
naling. Altered tubular function in old kidneys is likely
due to a combination of tubular loss, altered energy con-
sumption (as shown above), and a reduction in the tubu-
lar transport of electrolytes, ions, glucose, amino acids,
and organic acids manifested decreased expression of 12
different solute carrier family genes in addition to the
lysosomal ATPase, H+ transporting genes ATP6V1G3
and ATP6V1A1, the potassium voltage-gated channel
KCNAB2, and glucose-6-phosphate transporter G6PT1
(see also Supplemental Table 2, http://microarray-pubs.
stanford.edu/renalaging). An age-related loss of glu-
tathione synthesis had been described [35], leading to an
increased susceptibility to oxidative stress because of de-
creased antioxidative capacity. In old kidneys, decreased
GSH levels were due to decreased c-GCS activity [36].
Confirming this finding, we found reduced expression
in the old kidneys for the glutathione-related enzymes
GSTT1 and GSTA3, which play a protective role against
oxidative stress, and aldehyde oxidase 1 (AOX1), which
produces hydrogen peroxide and can catalyze the forma-
tion of superoxide.
A surprising finding was evidence of an increased im-
mune and inflammatory response in old kidneys [im-
munoglobulin genes: IgLa, IgKC, IgJ, IgLJ3, the T cell
receptor delta locus (TRD), high-affinity IgE receptor
FCER1A, immediate early protein gene ETR101, and
the natural killer cell activator PRG2]. These changes
may be a nonspecific inflammatory response to chronic
tissue injury with age. Genes whose products affect telom-
ere function and maintenance such as POT1, TERF1, and
TERF2 were not altered. P16INK4a, the gene that has pre-
viously been shown to have increased expression with
renal aging [11, 13], was not present on the array plat-
form for study. The somatostatin receptor, protein ser-
ine/threonine kinase HAK, and Thy-1 cell surface antigen
(THY1) genes all show increased expression in senescent
fibroblasts [37] and were increased in old kidney samples,
with the greatest difference between the young and old
kidneys. These genes are among a mitogen-activated pro-
tein kinase cascade recently implicated in experimental
mesangioproliferative glomerulonephritis [38].
Unlike old kidneys, adult kidney samples showed
robust expression for genes associated with epithelial
transport (glucose-6-phosphate transporter G6PT1; H+
transporter ATP6VIG3, cytochrome P8B1), mitochon-
drial function (PCK2, MIRO-2, electron transporter
ETFB, NDUFA10), hormone synthesis (corticotrophin
and thyrotrophin proteins, and TRHDE), tubular func-
tion, and urinary concentration (natriuretic peptide re-
ceptor, NPR2, SLC6A12).
Young kidney samples, ranging in age between 8 weeks
and 8 years, showed considerable intergroup variability
in expression profiles. Fetal collagen COL3A1 and cy-
clin B2 and CDC25, the latter promoting the cell cycle at
the G2/M transition [33], were significantly increased in
young relative to the adult kidneys (SAM significance q =
1.3%). Young kidneys, unlike the adult kidneys, showed
evidence of increased extracellular matrix synthesis and
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Table 2. cDNA clones identified that differentiate kidney samples with high- and low- histopathology scores from elderly patients
Symbol Definition Fold Accession Clone Age
CSPG2 Chondroitin sulfate proteoglycan 2 3.64 AA056022 IMAGE:377701 Yes
IGLJ3 Immunoglobulin lambda joining 3 3.55 T67053 IMAGE:66560 Yes
CDW52 CAMPATH-1 antigen 3.33 AI826477 IMAGE:2417330 Yes
TNC Tenascin C (hexabrachion) 3.24 AW075585 IMAGE:2577230 Yes
TNFRSF12A Tumor necrosis factor receptor 12A 3.20 R33355 IMAGE:135791 No
IGJ Immunoglobulin J peptide (alpha and mu) 3.17 T70057 IMAGE:80948 Yes
CDC25C M-phase inducer phosphatase 3 3.04 W95000 IMAGE:415102 Yes
ESPL1 Extra spindle pole like 2.74 AI816969 IMAGE:2409751 Yes
FN1 Fibronectin 1 2.38 R62612 IMAGE:139009 Yes
COL16A1 Collagen, type XVIa1 2.33 AA088202 IMAGE:488258 No
LTBP1 Latent transforming growth factor binding 2.31 AW025698 IMAGE:2516260 No
DGKA Diacylglycerol kinase alpha 2.10 AA026130 IMAGE:366944 No
SLC31A1 Copper transporter member 1 −4.21 AA608729 IMAGE:950924 Yes
GDA Guanine deaminase −4.03 R12516 IMAGE:25984 Yes
PLGL Plasminogen-like −3.87 H90507 IMAGE:241537 Yes
CALML3 Calmodulin-like 3 −3.51 AA055522 IMAGE:377348 Yes
CDR1 Cerebellar degeneration-related −3.37 AA985354 IMAGE:1629478 Yes
BPHL Serine hydrolase −3.04 AA169798 IMAGE:610097 Yes
ASS Argininosuccinate synthetase −2.95 AA676466 IMAGE:882522 Yes
AK3 Adenylate kinase 3 −2.88 AA947132 IMAGE:1553394 Yes
CYP8B1 P450 Sterol 12-alpha-hydroxylase −2.77 AA928708 IMAGE:1553245 Yes
BHMT2 Betaine-homocysteine methyltransferase −2.75 AA745686 IMAGE:1322845 Yes
PDCD8 Programmed cell death 8 −2.73 AA932997 IMAGE:1554541 Yes
PRKWNK1 Protein kinase, lysine deficient 1 −2.65 H89604 IMAGE:240174 Yes
ALDH6A1 Aldehyde dehydrogenase 6A1 −2.58 AA196160 IMAGE:627687 Yes
SLC13A3 Sodium-dependent dicarboxylate transporter −2.53 H18950 IMAGE:51406 Yes
GPD1 Glycerol-3-phosphate dehydrogenase −2.50 AI300352 IMAGE:1901097 Yes
FABP1 Fatty acid binding protein −2.50 T53219 IMAGE:68557 Yes
PLG Plasminogen −2.50 R91117 IMAGE:195040 Yes
LOC113251 c-Mpl binding protein −2.47 AI240426 IMAGE:1856516 Yes
HCN3 Nucleotide-gated potassium channel −2.47 H77541 IMAGE:234522 Yes
DDC Dopa decarboxylase −2.36 AI261686 IMAGE:2028959 Yes
APOE Apolipoprotein E −2.35 AA947607 IMAGE:1590208 Yes
PSA Phosphoserine aminotransferase −2.33 AI015679 IMAGE:1636108 Yes
RPC8 RNA polymerase III subunit RPC8 −2.31 H99699 IMAGE:262932 Yes
DIO1 Deiodinase, iodothyronine −2.29 N74025 IMAGE:296702 Yes
NEO1 Neogenin homolog 1 −2.28 AA447658 IMAGE:784959 No
PCYT1B Phosphate cytidylyltransferase −2.23 AI247953 IMAGE:1848986 Yes
SLC7A7 Cationic amino acid transporter −2.16 T98393 IMAGE:122063 Yes
G6PT1 Glucose-6-phosphate transporter −2.13 AA490159 IMAGE:839980 Yes
HNF4A Hepatocyte nuclear factor 4 −2.12 AI301528 IMAGE:1899437 Yes
NEDD5 Neural precursor cell expressed −2.10 T39376 IMAGE:60565 Yes
SGK2 Serum/glucocorticoid regulated kinase −2.08 AA045601 IMAGE:509610 No
Fold expression differences between adult and high-histopathology old sample groups are reported.
turnover across a similar gene-set, as seen in old kidneys
(MMP7, FN1, TNC, CSPG2, SERPINA3, OSF-2) and
growth (LCN2). c-FOS and JUN, genes downstream in
the TGFb-signaling pathway, were over 3-fold higher in
the young than adults and up to 5-fold higher in the young
than in the old (SAM multiclass response significance
scores q = 1.5% and 2.36%, respectively).
Immunohistochemistry for CD79
To better understand the foundation of differences ob-
served in inflammatory response genes within the kid-
neys, immunohistochemistry for the B cell and plasma
cell surface antigen CD79 was performed on all samples.
A strong correlation was seen between CD79 staining
(number of cells/mm2 by blinded biopsy analysis) and in-
terstitial fibrosis scores (R2 = 0.79), with a weaker corre-
lation of CD79 density and age (R2 = 0.55). This suggests
that the increased expression of immunoglobulin genes
seen in the old kidneys may be secondary to increased
number of activated B cells and/or plasma cells in aging
kidneys (data not shown).
Correlation of gene expression signatures
with histopathology
The degree of glomerular sclerosis, interstitial fibro-
sis, tubular atrophy, and fibrous intimal thickening were
correlated with gene expression levels across adult and
old renal samples (see Methods for data filtering cri-
teria used). Using quantitative response analysis for
the four pathology groups, SAM identified total of 255
genes; 163 genes correlated with interstitial fibrosis, 83
with fibrous intimal thickening, 38 genes with glomeru-
lar sclerosis, and 8 genes with tubular atrophy (FDR
threshold of q<12.5% used for all datasets; the functional
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Fig. 2. Kidney samples from three age groups. Expression measurements of 505 differentially expressed genes identified by multiclass analysis
using the Statistical Analysis of Microarray program (SAM version 3, 2003) were clustered by expression similarity. The color in each cell reflects
the expression level of the genes in the corresponding sample, relative to its mean expression level across the entire set of biopsy samples. Gray
represents missing or excluded data. The log2 fluorescence ratio scale extends from of 0 to 2 relative to the mean level for all samples and the
positions of major groups of genes are indicated. Names of the genes confirmed by real-time PCR in this study are underlined. All expression data
in this cluster are available on the web supplement at http://microarray-pubs.stanford.edu/renalaging/.
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Fig. 3. Genes associated with four renal pathology measurements. Re-
nal tissue adjacent to that sampled for mRNA expression analysis were
scored for glomerulosclerosis (Gs), tubular atrophy (TA), interstitial
fibrosis (IF), and fibrous intimal thickening (FIT). Correlation of these
pathology scores to gene expression was performed by SAM quanti-
tative response and a significance threshold of q<12.5% set for each
parameter. The number of cDNA clones associated with each param-
eter is listed, as well as the number of genes in common between each
group.
gene ontology groups are also shown for this dataset in
Supplemental Table 2; http://microarray-pubs.stanford.
edu/renalaging/). About half of this renal-pathology gene
set (N = 128/255) overlaps with the renal-aging gene
set (N = 505 genes). Similar ontology groups (multiple
genes involved in apoptosis, cell adhesion, ion and glucose
transport, cell proliferation, extracellular matrix, energy
metabolism/mitochondrial genes, growth factors, stress
response, and inflammatory response) were represented
in both gene sets. Figure 3 shows that genes specifically
altered in expression in kidneys with glomerulosclerosis
and interstitial fibrosis have the greatest degree of over-
lap, and this is also reflected in the high degree of corre-
lation between these two parameters across the full data
set (R2 = 0.72).
Hierarchic clustering across the 255 renal-pathology
gene set was performed to examine the expression sim-
−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−→
Fig. 4. Hierarchic clustering of samples based on genes that correlate with renal histopathology scores. (A) Quantitative response analysis using
SAM identified 163 genes whose expression levels correlate with IF, 38 genes with GS, 8 genes with TA, and 83 with FIT (false discovery rate
threshold of q<12.5%). Combined this renal-pathology set of 255 genes were used to group kidney samples using complete hierarchic clustering of
both genes and arrays. The dendrogram indicates that 4 of the old samples (O1, O6, O8, O9) cluster together with the adult samples. (B) Hierarchic
clustering of the old and adult samples across the renal-aging gene set (N = 505 genes) revealed that the same old samples cocluster with the adults.
(C) Hierarchic clustering of 16 nonpediatric kidney samples on the basis of 67 cDNA transcripts identified by PAM comparing adults with five
kidneys from old donors (O2, O3, O4, O5, and O7) in the test set and the remaining other old kidney samples (O1, O6, O8, and O9) as the learning
set. (D) The four OA samples in the learning set all phenotype as similar to adults and cocluster with the adult kidney samples. (E) A total of
52 genes of known function are represented in the PAM classification analysis and there is substantial overlap between these genes with both the
human renal-aging and renal-pathology associated genes. The most significant percentage overlap in this analysis is highlighted. All expression data
in these clusters are available on the web supplement at http://microarray-pubs.stanford.edu/renalaging/.
ilarity across adult and old samples. The adult samples
clustered together while old samples split into two groups
(Fig. 4A). Similarly, hierarchic clustering of the renal-
aging gene set across only the adult and old samples
showed identical groupings of the old samples (Fig. 4B).
To understand which histopathologic parameter might
be driving separation of the old samples, samples were
reclustered across genes specific for each of the four
chronicity scores (data not shown). Interstitial fibrosis
was the only parameter that groups the old samples con-
sistent with both the age-related genes and the composite
pathology set, suggesting that interstitial fibrosis drives
the clustering of both sets of genes. To identify the most
highly contributing genes, we used the class prediction
tool PAM to identify a minimum set of 79 cDNA clones
(∼37% are ESTs) (Fig. 4C), and the high confidence class
prediction scores correlate with this grouping (Fig. 4D).
In addition, there is significant overlap between this set
of genes and ones associated with renal age or pathol-
ogy (Fig. 4E). Among the most highly predictive set of
clones are 43 known genes with expression differences of
two-fold or greater, as reported in Table 2.
In addition to scoring all kidney samples for interstitial
fibrosis (%IF), quantitation of cortical fractional inter-
stitial fibrosis volume (Vint) was performed with com-
puterized image analysis on coded sections stained using
Sirius red [39] and correlation to expression measure-
ments tested. As previously observed, the two scoring
methods for measuring fibrotic changes in the kidney pos-
itively correlate [40], although not strongly (R = 0.37;
data not shown). The expression of none of the genes an-
alyzed statistically correlate with Vint scores (minimum
FDR 23%) although several collagens (COL4A4, 4A2,
5A2 and 3A1) and FN1 are among the top 200 ranked
transcripts. These genes were also found to be age related
in this study and are known to specifically stain with the
Sirius red dye. Further, the top ranked genes also segre-
gate AO and OO samples by cluster analysis (data not
shown).
Real-time PCR analysis of selected genes
Expression differences of six age-related candidate
genes were confirmed by real-time PCR analysis. Of
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Fig. 5. Taqman-based analysis of gene expression in adult and old kidneys. Six genes, serine proteinase inhibitor (SERPIN3A), biphenyl hydrolase-
like (BPHL), tenascin (TNC), chondroitin sulfate proteoglycan 2 (CSPG2), fibronectin (FN1), and matrix metalloproteinase 7 (MMP7), were chosen
based on high significance scoring by SAM with renal aging. Four genes were also found among the renal-pathology associated genes (BPHL, TNC,
CSPG2, FN1). (A) Taqman PCR results confirmed increased or decreased expression of all the genes in the 16 nonpediatric samples tested in the
gene array analysis. The magnitude of the mean expression differences are indicated as fold differences for either gene array or Taqman PCR and
are generally higher for the Taqman PCR results. The differences between adult and old samples were significant for all and approached significance
for BPHL. (B) A separate test group of 17 kidneys (3 adult and 14 old kidneys) was used to validate differential expression of these genes with
age. Increased significance in the differential expression by age was observed for all genes, except SERPIN3A and BPHL. (C) Expression of the
proteoglycan CSPG2, whose array-based expression data was ranked with highest significance both by PAM and by SAM, was not only significantly
different between adult and old kidneys, but differences in expression within two identified groups of old samples (OO vs. OA) is also confirmed.
these, four are also found in the SAM analysis for re-
nal pathology. Three are related to fibrosis and growth
response: FN1, TNC, and MMP7. MMP7 has also been
implicated in tissue remodeling and wound healing and
is know to regulate the activity of various defensin genes
[41]. CSPG2 is both a component basement membrane
[42] and was shown to be a direct target of p53 [43]. The
SERPIN3A, which may be a causative of atherothrom-
botic infarction [44], was examined for decreased ex-
pression in the older age groups. Similarly, biphenyl
hydrolase-like (BPHL), primarily expressed in liver and
kidney, has a potential enzymatic role in detoxification
processes, and was proposed to be reduced with age.
Collectively, differences in the expression of these genes
could be envisioned to play a key role in renal aging.
There was good correlation between array and real-
time PCR for all of these genes (SERPIN3A R = 0.71,
BPHL R = 0.83, TNC R = 0.83, CSPG2 R = 0.67, FN1
R = 0.63, MMP7 R = 0.79) (Fig. 5A). The magnitude
of the mean differences between old and adult were
generally higher for the Taqman PCR results, consistent
with previous array-based expression studies [45, 46]. The
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comparison between old and adult samples were signifi-
cant for all genes and approached significance for BPHL;
P = 0.072.
A separate test group of 17 kidneys (3 adult and 14
old kidneys) was used to validate the expression of these
genes in age (Fig. 5B). Increased significance in the dif-
ferential expression by age was observed for all genes,
except for SERPIN3A and BPHL, for which significance
was no longer reached. Among the genes tested using
quantitative PCR, only CSPG2 differentiated OO and
OA kidneys. Expression of the proteoglycan CSPG2 is,
thus, higher in old kidneys than adult kidneys, and differ-
entiated the OO and OA kidneys (P = 0.029; Fig. 5C).
DISCUSSION
We studied the gene expression profiles of kidney from
individuals of different ages and observed expression sig-
natures in old kidney consistent with the known changes
of aging, such as fibrosis, cellular aging, and low-grade
focal inflammation. The major change of human renal
aging—loss of mass—would of course produce no tran-
scripts in its established state; there are no transcripts
in nephrons that are not there. The change would be de-
tectable as functional units in the process of being lost and
as interstitium remodeling with age. The results are com-
patible with the concept that not only is there loss of mass,
but the existing tissue is altered, perhaps contributing to
reduced capacity of the aged nephron to withstand stress.
These expression changes, however, are subtle and only
account for only 2% of the initial gene set of 13,930 genes
and less than 18% of the differentially expressed genes
analyzed, which explains why the samples do not clus-
ter by age across these gene sets. Another reason for the
small overall gene expression differences seen between
the samples may result from the rather mild chronicity
scores in all the old kidneys (which are ∼1/3 lower than
renal chronicity scores, with age that were reported in
some other studies [30–34]). Nevertheless, appreciable
transcript differences are observed when adult kidneys
are compared to high-functioning old kidneys. In young
adults, renal architecture and function are at their peak,
while chronic tubular and interstitial changes are known
to accrue with age, resulting in loss of glomerular and
single nephron filtration after 40 years of age [47]. Se-
lection of gene expression specific for age by supervised
analysis results in clustering of all adults together, with
exception of the oldest adult in this group (aged 46), who
clusters with old samples. In contrast, the old kidneys
separate into two distinct groups: old kidneys that seg-
regate together with adults (N = 4, termed OA in this
study) or away from the adults (N = 5, termed OO in
this study). Class prediction analysis to evaluate which
genes that drive these differences narrows the differential
genes to a list of 50 known unique genes, of which
86% overlap with the renal-aging genes and 50% over-
lap with the renal-pathology genes. This confirms that
age-related pathology correlates with age-related tran-
scriptome changes, but also indicates that the age-related
transcriptome changes go beyond what the pathology can
assess. A significant enrichment of genes associated with
the number of sclerotic glomeruli (24%) and the amount
of interstitial fibrosis (14%) is observed, while fibrous in-
timal thickening and tubular atrophy play little or no role
in this segregation, as evidenced by insignificant enrich-
ment (0% and 1.2%, respectively). CSPG2 is expressed
at highest levels in the OO kidneys in this study and ex-
pression of this gene alone segregates the OO and OA
old kidneys. It is possible that the signature of tubular
atrophy may be faint because these tubules may be tran-
scriptionally inactive, or that the signature of arteries may
be too infrequent to contribute the overall kidney signal.
Aging kidney signatures, as expected in a cross-
sectional study, were not linearly related to age, gender,
or individual histopathologic parameters. Old kidneys
show reduced tubular transport, active cellular processes
including cell cycling, energy metabolism, and recovery
from oxidative stress and tissue injury. The altered bal-
ance between expression of growth factor and extracel-
lular matrix components in the old kidneys likely results
in the incremental tissue chronicity with age. In this con-
text, reduced expression of key genes in energy pathways,
ion transport, and response to oxidative stress in renal
epithelial cells could contribute to reduced capacity of
the aged nephron to withstand stress [1]. In contrast, the
increased expression of genes involved in extracellular
matrix restructuring and the inflammatory response are
more likely derived from either resident fibroblasts or
from infiltrating immune cells, respectively. A significant
loss of tubular mass is seen with age and it is likely that
cumulative environmental stress (e.g., oxidative damage)
associated with the normal process of aging may evoke
an inflammatory response linked to nephron loss and ma-
trix remodeling. Aged kidneys develop mild mononu-
clear cell infiltrates similar to those in any kidney with
low-grade fibrosis and atrophy and, thus, the inflamma-
tory genes are expected. Thus, the increased expression
of immune-specific genes (especially chemokines and im-
munoglobulin genes) is consistent with the increased infil-
tration of B cells in old kidneys in general and in this study.
Chronic organ injury has been shown to have a focal in-
crease in B cell content. The basis for the link between
nephron loss with fibrosis and atrophy and mononuclear
infiltration is not known, although they are probably
a consequence rather than a cause of the fibrosis and
atrophy.
A paucity of cell turnover and metabolism is seen in
the old kidneys in this study, consistent with the nor-
mal functioning of the surviving nephrons in healthy old
kidneys [6, 9]. An increase of apoptosis-related genes
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was observed, although apoptosis-related genes account
for only 2% of the genes associated with renal aging.
CSPG2, a p53 regulated gene, is highly differentially ex-
pressed with renal aging and its expression is highest in
the old kidneys. CSPG2 encodes versican, which is in-
duced in a p53-dependant manner in response to specific
genotoxic stress [43]. p53 is expressed ubiquitously in all
cell types, including fibroblasts, and becomes active when
cells are subjected to a variety of cellular insults, such as
DNA damage, leading to the arrest of cell proliferation or
apoptosis. Recently, we have shown that p53 is not tran-
scriptionally regulated in renal aging [13], although its
expression is increased in senescent fibroblasts. CSPG2 is
a component of the basement membrane in tubular cells
[42], and is also expressed in senescent fibroblasts ([37];
http://source.stanford.edu). This gene is also secreted into
the extracellular matrix, where it is present in all 3 lay-
ers of veins and elastic arteries, with increased expression
in atherosclerotically transformed vessel walls. It is note-
worthy that CSPG2 is expressed in highest levels in the
OO old kidneys in this study, which, although marginally
higher in standard pathology scoring, cannot otherwise be
differentiated on standard pathology scoring. This obser-
vation suggests that CSPG2 may play a role in increased
tubular basement membrane matrix deposition, leading
to tubular basement membrane thickening, interstitial fi-
brosis, and intimal thickening.
A number of genes known to be associated with age or
senescence in vitro in other studies were confirmed by the
current study. Genes expressed in senescent fibroblasts
(HAK, Thy1, transgelin) are significantly lower in young
kidney samples. Another area of active research in aging
is the influence of the insulin/insulin-like growth factor
pathway signaling. In Caenorhabditis elegans, mutations
in a number of genes in this pathway result in dramatic
increases or decreases of lifespan [48, 49], and altered ex-
pression of several genes have been observed as a result
these genetic changes [50]. Although we did not observe a
difference in the expression of insulin/insulin-like growth
factor or its receptor, we did find that genes known to be
up-regulated in the long-lived daf-2 mutant also show al-
tered expression in renal aging (cytochrome P450 family,
aquaporin, glyceraldehyde-3-phosphate dehydrogenase,
fibroblast growth factor, and genes involved in tertahy-
drofolate metabolism and UDP glycosylation).
The present results are compatible with aging being not
just loss of mass but alterations in the remaining tissue,
which could be useful in defining genes whose expression
could predict the performance of old kidneys after renal
transplantation. Clinicians need molecular markers that
will accurately predict whether a deceased donor kidney
from an old donor has a high probability of recovering
function in a new host following the stresses of brain
death, preservation, implantation, etc. New validated
transcriptosome-based criteria for predicting kidney per-
formance and functional reserve would permit more kid-
neys from older donors to be transplanted, expanding
organ donor pools. Currently, kidneys with reasonable
function in the old age group are considered acceptable
for transplantation only on the basis of criteria such as
glomerulosclerosis on biopsy that in fact have poor pre-
dictive value. We need to add predictive power, so that
the problems of old kidneys can be estimated more accu-
rately (e.g., the rate of primary nonfunction, delayed graft
function, and graft survival) [51]. Improved methods of
monitoring for “tissue senescence” are required, which
results from a combination of age and/or environmental
stress-dependent modification of cellular function. It is
notable that the oldest kidney in this study belonged to
an 88-year-old, but it coclustered with adult kidneys in
all supervised analysis. We believe that the degree of tis-
sue senescence, which may be more accurately predicted
by molecular markers, such as CSPG2, identified in this
study, will likely be inversely correlated with subsequent
performance of the kidney after stress, such as transplan-
tation. Testing this hypothesis will require prospective
screening of kidney donors and correlating the results
with immediate and late outcomes, with subsequent adap-
tations of technology to make the promising information
available to clinicians in a cost-effective and timely man-
ner. In addition, extending the patient population to a
non-Caucasian cohort is merited.
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